SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-21-065468
Filing Date
2021-03-02
Accepted
2021-03-02 16:02:44
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1 d97958ds1.htm S-1 722205
2 EX-1.1 d97958dex11.htm EX-1.1 209484
3 EX-5.1 d97958dex51.htm EX-5.1 8682
4 EX-23.2 d97958dex232.htm EX-23.2 1739
5 GRAPHIC g97958g03h85.jpg GRAPHIC 26092
6 GRAPHIC g97958g05a02.jpg GRAPHIC 106996
7 GRAPHIC g97958g08h03.jpg GRAPHIC 134257
8 GRAPHIC g97958g62r70.jpg GRAPHIC 99574
9 GRAPHIC g97958g68v77.jpg GRAPHIC 2907
  Complete submission text file 0001193125-21-065468.txt   1453354
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: S-1 | Act: 33 | File No.: 333-253783 | Film No.: 21703455
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences